Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 106 is a non-functional pseudogene related to the 5S ribosomal RNA gene cluster. It exists within the human genome as a result of gene duplication or retrotransposition but does not produce a functional ribosomal RNA or have a known coding or non-coding product[5][4]. Pseudogenes like RNA5SP106 are typically considered "genomic fossils," though in some cases elsewhere in the genome, pseudogene transcripts may have regulatory effects. However, RNA5SP106 itself has not been associated with any functional biological activity, roles in disease, or relevance as a therapeutic target[2][5]. This target does not represent a protein or RNA with any known therapeutic, biomarker, or regulatory importance, and there are no associated drugs or safety concerns[5][2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 106 (RNA5SP106).